p53-mediated autophagic regulation: A prospective strategy for cancer therapy

Cancer Letters

Volumn 363, Issue 2, 2015, Pages 101-107

  Tang, Juanjuan ^a   Di, Jiehui ^a,b   Cao, Huan ^a   Bai, Jin ^a   Zheng, Junnian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; P53; Target gene; Therapy; Tumorigenesis

Indexed keywords

PROTEIN P53;

AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER THERAPY; CELLULAR DISTRIBUTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSACTIVATION; ENERGY METABOLISM; GENETICS; LYSOSOME; NEOPLASMS; PATHOLOGY;

AUTOPHAGY; ENERGY METABOLISM; HUMANS; LYSOSOMES; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929266266     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.04.014     Document Type: Review

References (110)

1. Tsujimoto Y., Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ 2005, 12(Suppl. 2):1528-1534.
2. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
3. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol. Cell 2010, 40:280-293.
4. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
5. Mizushima N., Yoshimori T., Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol 2011, 27:107-132.
6. Rubinsztein D.C., Shpilka T., Elazar Z. Mechanisms of autophagosome biogenesis. Curr. Biol 2012, 22:R29-R34.
7. Klionsky D.J., Cregg J.M., Dunn W.A., Emr S.D., Sakai Y., Sandoval I.V., et al. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 2003, 5:539-545.
8. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet 2009, 43:67-93.
9. Yang Z., Klionsky D.J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol 2009, 335:1-32.
10. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev 2010, 90:1383-1435.
11. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
12. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7:961-967.
13. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747.
14. Rosenfeldt M.T., Ryan K.M. The role of autophagy in tumour development and cancer therapy. Expert Rev. Mol. Med 2009, 11:e36.
15. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
16. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
17. Iacobuzio-Donahue C.A., Herman J.M. Autophagy, p53, and pancreatic cancer. N. Engl. J. Med 2014, 370:1352-1353.
18. Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene 2007, 26:2145-2156.
19. Zilfou J.T., Lowe S.W. Tumor suppressive functions of p53. Cold Spring Harb. Perspect. Biol 2009, 1:a001883.
20. Muller P.A., Vousden K.H. p53 mutations in cancer. Nat. Cell Biol 2013, 15:2-8.
21. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
22. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
23. Toledo F., Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 2006, 6:909-923.
24. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol 2008, 9:402-412.
25. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
26. Sui X., Jin L., Huang X., Geng S., He C., Hu X. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy 2011, 7:565-571.
27. Maiuri M.C., Galluzzi L., Morselli E., Kepp O., Malik S.A., Kroemer G. Autophagy regulation by p53. Curr. Opin. Cell Biol 2010, 22:181-185.
28. Crighton D., Ryan K.M. Splicing DNA-damage responses to tumour cell death. Biochim. Biophys. Acta 2004, 1705:3-15.
29. Feng Z., Zhang H., Levine A.J., Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8204-8209.
30. Budanov A.V., Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
31. Maiuri M.C., Malik S.A., Morselli E., Kepp O., Criollo A., Mouchel P.L., et al. Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 2009, 8:1571-1576.
32. Feng Z., Hu W., de Stanchina E., Teresky A.K., Jin S., Lowe S., et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007, 67:3043-3053.
33. Feng Z. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb. Perspect. Biol 2010, 2:a001057.
34. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995, 377:646-649.
35. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P.R., et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
36. Crighton D., Wilkinson S., Ryan K.M. DRAM links autophagy to p53 and programmed cell death. Autophagy 2007, 3:72-74.
37. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
38. Zhang X.D., Wang Y., Wang Y., Zhang X., Han R., Wu J.C., et al. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 2009, 5:339-350.
39. Mah L.Y., O'Prey J., Baudot A.D., Hoekstra A., Ryan K.M. DRAM-1 encodes multiple isoforms that regulate autophagy. Autophagy 2012, 8:18-28.
40. Crighton D., O'Prey J., Bell H.S., Ryan K.M. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ 2007, 14:1071-1079.
41. Rosenbluth J.M., Mays D.J., Pino M.F., Tang L.J., Pietenpol J.A. A gene signature-based approach identifies mTOR as a regulator of p73. Mol. Cell. Biol 2008, 28:5951-5964.
42. Gozuacik D., Kimchi A. DAPk protein family and cancer. Autophagy 2006, 2:74-79.
43. Harrison B., Kraus M., Burch L., Stevens C., Craig A., Gordon-Weeks P., et al. DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J. Biol. Chem 2008, 283:9999-10014.
44. Zalckvar E., Berissi H., Eisenstein M., Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 2009, 5:720-722.
45. Zalckvar E., Berissi H., Mizrachy L., Idelchuk Y., Koren I., Eisenstein M., et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep 2009, 10:285-292.
46. Sugars K.L., Budhram-Mahadeo V., Packham G., Latchman D.S. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res 2001, 29:4530-4540.
47. Maiuri M.C., Criollo A., Tasdemir E., Vicencio J.M., Tajeddine N., Hickman J.A., et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3:374-376.
48. Levine B., Sinha S., Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
49. Martoriati A., Doumont G., Alcalay M., Bellefroid E., Pelicci P.G., Marine J.C. dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 2005, 24:1461-1466.
50. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999, 13:2658-2669.
51. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol 2001, 2:731-737.
52. Lorin S., Hamai A., Mehrpour M., Codogno P. Autophagy regulation and its role in cancer. Semin. Cancer Biol 2013, 23:361-379.
53. Abida W.M., Gu W. p53-Dependent and p53-independent activation of autophagy by ARF. Cancer Res 2008, 68:352-357.
54. Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M., et al. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol. Cell 2006, 22:463-475.
55. Itahana K., Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 2008, 13:542-553.
56. Reef S., Shifman O., Oren M., Kimchi A. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene 2007, 26:6677-6683.
57. Reef S., Kimchi A. Nucleolar p19ARF, unlike mitochondrial smARF, is incapable of inducing p53-independent autophagy. Autophagy 2008, 4:866-869.
58. Pimkina J., Humbey O., Zilfou J.T., Jarnik M., Murphy M.E. ARF induces autophagy by virtue of interaction with Bcl-xl. J. Biol. Chem 2009, 284:2803-2810.
59. Pimkina J., Murphy M.E. Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function. Cancer Biol. Ther 2011, 12:503-509.
60. Budina-Kolomets A., Hontz R.D., Pimkina J., Murphy M.E. A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction. Autophagy 2013, 9:1553-1565.
61. Grenier K., Kontogiannea M., Fon E.A. Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy. J. Biol. Chem 2014, 289:29519-29530.
62. Du Y., Yang D., Li L., Luo G., Li T., Fan X., et al. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 2009, 5:663-675.
63. Valbuena A., Castro-Obregon S., Lazo P.A. Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway. PLoS ONE 2011, 6:e17320.
64. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 2008, 30:678-688.
65. Pattingre S., Bauvy C., Carpentier S., Levade T., Levine B., Codogno P. Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J. Biol. Chem 2009, 284:2719-2728.
66. Lorin S., Borges A., Ribeiro Dos Santos L., Souquere S., Pierron G., Ryan K.M., et al. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res 2009, 69:6924-6931.
67. Lorin S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy. Autophagy 2010, 6:153-154.
68. Park K.J., Lee S.H., Lee C.H., Jang J.Y., Chung J., Kwon M.H., et al. Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem. Biophys. Res. Commun 2009, 382:726-729.
69. Zhang X.Y., Wu X.Q., Deng R., Sun T., Feng G.K., Zhu X.F. Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells. Cell. Signal 2013, 25:150-158.
70. Chikh A., Sanza P., Raimondi C., Akinduro O., Warnes G., Chiorino G., et al. iASPP is a novel autophagy inhibitor in keratinocytes. J. Cell Sci 2014, 127:3079-3093.
71. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
72. Green D.R., Chipuk J.E. p53 and metabolism: inside the TIGAR. Cell 2006, 126:30-32.
73. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009, 28:3015-3026.
74. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol 2008, 10:676-687.
75. Tasdemir E., Chiara Maiuri M., Morselli E., Criollo A., D'Amelio M., Djavaheri-Mergny M., et al. A dual role of p53 in the control of autophagy. Autophagy 2008, 4:810-814.
76. Tasdemir E., Maiuri M.C., Orhon I., Kepp O., Morselli E., Criollo A., et al. p53 represses autophagy in a cell cycle-dependent fashion. Cell Cycle 2008, 7:3006-3011.
77. Morselli E., Tasdemir E., Maiuri M.C., Galluzzi L., Kepp O., Criollo A., et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008, 7:3056-3061.
78. Balaburski G.M., Hontz R.D., Murphy M.E. p53 and ARF: unexpected players in autophagy. Trends Cell Biol 2010, 20:363-369.
79. You H., Yamamoto K., Mak T.W. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9051-9056.
80. Morselli E., Shen S., Ruckenstuhl C., Bauer M.A., Marino G., Galluzzi L., et al. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle 2011, 10:2763-2769.
81. Naidu S.R., Lakhter A.J., Androphy E.J. PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy. Cell Cycle 2012, 11:2717-2728.
82. Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z., Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18511-18516.
83. Ringer L., Sirajuddin P., Tricoli L., Waye S., Choudhry M.U., Parasido E., et al. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget 2014, 5:10678-10691.
84. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304:596-600.
85. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004, 64:2350-2356.
86. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ 2006, 13:994-1002.
87. Gao W., Shen Z., Shang L., Wang X. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ 2011, 18:1598-1607.
88. Rao S., Tortola L., Perlot T., Wirnsberger G., Novatchkova M., Nitsch R., et al. A dual role for autophagy in a murine model of lung cancer. Nat. Commun 2014, 5:3056.
89. Lassus P., Ferlin M., Piette J., Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J. 1996, 15:4566-4573.
90. Rosenfeldt M.T., O'Prey J., Morton J.P., Nixon C., MacKay G., Mrowinska A., et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013, 504:296-300.
91. Guo J.Y., Karsli-Uzunbas G., Mathew R., Aisner S.C., Kamphorst J.J., Strohecker A.M., et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 2013, 27:1447-1461.
92. Guo J.Y., Xia B., White E. Autophagy-mediated tumor promotion. Cell 2013, 155:1216-1219.
93. Gewirtz D.A. The four faces of autophagy: implications for cancer therapy. Cancer Res 2014, 74:647-651.
94. Gewirtz D.A. The autophagic response to radiation: relevance for radiation sensitization in cancer therapy. Radiat. Res 2014, 182:363-367.
95. Bristol M.L., Di X., Beckman M.J., Wilson E.N., Henderson S.C., Maiti A., et al. Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3. Autophagy 2012, 8:739-753.
96. Bristol M.L., Emery S.M., Maycotte P., Thorburn A., Chakradeo S., Gewirtz D.A. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?. J. Pharmacol. Exp. Ther 2013, 344:544-552.
97. Carew J.S., Medina E.C., Esquivel J.A., Mahalingam D., Swords R., Kelly K., et al. Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J. Cell. Mol. Med 2010, 14:2448-2459.
98. Ding Z.B., Hui B., Shi Y.H., Zhou J., Peng Y.F., Gu C.Y., et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin. Cancer Res 2011, 17:6229-6238.
99. Godbole A.M., Purushottamachar P., Martin M.S., Daskalakis C., Njar V.C. Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts. Mol. Cancer Ther 2012, 11:898-908.
100. Wu Z., Chang P.C., Yang J.C., Chu C.Y., Wang L.Y., Chen N.T., et al. Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer 2010, 1:40-49.
101. Shi Y.H., Ding Z.B., Zhou J., Hui B., Shi G.M., Ke A.W., et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011, 7:1159-1172.
102. Rao R., Balusu R., Fiskus W., Mudunuru U., Venkannagari S., Chauhan L., et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol. Cancer Ther 2012, 11:973-983.
103. Wilson E.N., Bristol M.L., Di X., Maltese W.A., Koterba K., Beckman M.J., et al. A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm. Cancer 2011, 2:272-285.
104. Lim Y., Hedayati M., Merchant A.A., Zhang Y., Yu H.H., Kastan M.B., et al. Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation. Int. J. Radiat. Oncol. Biol. Phys 2012, 84:800-806.
105. Chaachouay H., Ohneseit P., Toulany M., Kehlbach R., Multhoff G., Rodemann H.P. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother. Oncol 2011, 99:287-292.
106. Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008, 68:1485-1494.
107. Gaudin D., Yielding K.L. Response of a "resistant" plasmacytoma to alkylating agents and x-ray in combination with the "excision" repair inhibitors caffeine and chloroquine. Proc. Soc. Exp. Biol. Med 1969, 131:1413-1416.
108. Maycotte P., Aryal S., Cummings C.T., Thorburn J., Morgan M.J., Thorburn A. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 2012, 8:200-212.
109. Chakradeo S., Sharma K., Alhaddad A., Bakhshwin D., Le N., Harada H., et al. Yet another function of p53: the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective. Implications for autophagy inhibition as a therapeutic strategy. Mol. Pharmacol 2015, 87:803-814.
110. Cheng G., Kong D., Hou X., Liang B., He M., Liang N., et al. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother. Radiopharm 2013, 28:153-159.